Found 4 matching trials
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma PHASE2 This experiment will test the safety and effectiveness of a treatment for m...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma PHASE1 This phase I trial tests the safety and side effects of STIL101 for injecti...
Show More Location
Multiple Locations
Learn More & Join Trial
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) PHASE1 The goal of this Phase I/II observational and interventional platform study...
Show More Location
Multiple Locations
Learn More & Join Trial
TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy PHASE2 This study evaluates the preliminary efficacy and safety of adjuvant therap...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial